Trigonelline is an NAD+ precursor that improves muscle function during ageing and is reduced in human sarcopenia

Mathieu Membrez, Eugenia Migliavacca, Stefan Christen, Keisuke Yaku, Jennifer Trieu, Alaina K. Lee, Francesco Morandini, Maria Pilar Giner, Jade Stiner, Mikhail V. Makarov, Emma S. Garratt, Maria F. Vasiloglou, Lucie Chanvillard, Emilie Dalbram, Amy M. Ehrlich, José Luis Sanchez-Garcia, Carles Canto, Leonidas G. Karagounis, Jonas T. Treebak, Marie E. MigaudRamin Heshmat, Farideh Razi, Neerja Karnani, Afshin Ostovar, Farshad Farzadfar, Stacey K.H. Tay, Matthew J. Sanders, Karen A. Lillycrop, Keith M. Godfrey, Takashi Nakagawa, Sofia Moco, René Koopman, Gordon S. Lynch, Vincenzo Sorrentino*, Jerome N. Feige*

*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

24 Scopus citations

Fingerprint

Dive into the research topics of 'Trigonelline is an NAD+ precursor that improves muscle function during ageing and is reduced in human sarcopenia'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science